A Severance Hospital research team has revealed that a hemostatic powder made from plant extracts significantly improves the success rate of initial hemostasis in patients with gastrointestinal bleeding caused by peptic ulcers.Peptic ulcers, which result from the digestive acid eroding the lining of
Professor Keum Ki-chang of radiation oncology at Yonsei University College of Medicine has been appointed as CEO and President of Yonsei University Health System (YUHS) and YUHS Vice President for Health Sciences, Severance Hospital said on Tuesday. His term will begin on March 1 and will last for f
The government has concluded that the recent death of a cardiac arrest patient in her 80s in Daejeon while being transported by ambulance was not related to "emergency rooms’ refusal to accept patients.”The Ministry of Health and Welfare said Tuesday that it reached such a conclusion after conductin
BeiGene, a global biotech firm founded in 2010 in Beijing, is strengthening its global presence by expanding its workforce and boosting sales.The company is waiting for the U.S. Food and Drug Administration (FDA) to approve its anti-PD-1 immuno-oncology drug Tevimbra (tislelizumab) this year, drawin
Starting next month, biliary tract cancer patients can add the anti-PD-L1 immunotherapy Imfinzi (durvalumab) at their own expense to the existing gemcitabine/cisplatin (GemCis) chemotherapy regimen for the first-line treatment of locally progressive or metastatic biliary tract cancer.It was part of
CG Bio said it has become the largest shareholder in Innosys, a research and manufacturing company focused on orthopedic implants, following the completion of an equity acquisition on Tuesday.The acquisition involved CG Bio finalizing share transfer agreements for a 17.75 percent stake in Innosys an
The Ministry of Food and Drug Safety has signed a mutual recognition agreement (MRA) with Singapore's Health Sciences Authority (HSA) to recognize the results of Good Manufacturing Practice (GMP) surveys of pharmaceutical manufacturing facilities between the two countries.Minister of Food and Drug S
A research team at CHA Bundang Medical Center has developed a promising solution for male infertility, particularly for patients suffering from Klinefelter syndrome.Klinefelter syndrome, characterized by the presence of an extra X chromosome (XXY instead of the typical XY), is the most common cause
Roche Korea hosted a two-day RISE (Roche Initiated Scientific Exchange) symposium on Thursday and Friday last week, shedding light on the clinical significance of the pioneering bispecific antibodies for blood cancer, Columvi (ingredient: glofitamap) and Lunsumio (mosunetuzumab).Comprising five sess
Pharos iBio will collaborate with the team of Professor Shin Sang-joon of the Department of Medical Oncology at Yonsei Cancer Center to conduct the translational study of PHI-501 under development for treating solid tumors.PHI-501 is a pipeline of solid tumor therapeutics in preclinical development.
Medytox has encountered a significant setback as the U.S. FDA has declined the biologics license application (BLA) for its innovative non-animal liquid botulinum toxin product, MT10109L, aimed at reducing moderate to severe glabellar (forehead) and lateral canthal (crow's feet) lines.The refusal, da
AriBio said Monday that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has formally approved POLARIS-AD, a global phase 3 clinical trial of AR1001, an oral treatment for Alzheimer's disease.AriBio plans to initiate the phase 3 trial in the U.K. before the end of the first quarte
The Korean government has made a formal proposal to the nation's medical community, urging them to appoint representative members to engage in discussions on critical issues such as the expansion of medical school quotas and the cessation of ongoing collective actions, including strikes and mass res
The first FGFR inhibitor for bladder cancer, Balversa (erdafitinib), will soon be launched in Korea.According to industry sources on Monday, Janssen Korea is gearing up to release Balversa without reimbursement in late March.Balversa is an FGFR (fibroblast growth factor receptor) inhibitor approved
The role of artificial intelligence (AI) is growing in the healthcare field. There are a lot of movements to incorporate AI. As global big tech companies, including Google and Microsoft, have made strides in healthcare AI, the area has evolved to the point where it is applied to real-world healthcar
Celltrion once again demonstrated the competitiveness of its Remsima SC at the 2024 European Crohn's and Colitis Organization (ECCO) congress in Stockholm, Sweden, from last Wednesday to Saturday by receiving favorable reviews from overseas medical professionals.At the ECCO, attended by more than 8,
GC Cell has signed an agreement to transfer the processing technology of its flagship anticancer immune cell therapy, Immuncell-LC Injection, to BioCentriq, its U.S. affiliate, and a cell therapy CDMO company.Through this process technology transfer cooperation, GC Cell and Biocentriq expect to prov
JW Shinyak said Monday it has signed a collaborative research agreement with C&C Research Laboratories, a subsidiary of JW Pharmaceutical, to develop innovative anticancer cell therapies.Under the agreement, JW Shinyak will develop a new CAR-NK cell therapy targeting solid tumors with C&C Research L
Samsung Bioepis said that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Pyzchiva, also known as SB17, a biosimilar candidate referencing Stelara, last Sunday. This biosimilar, referencing Janssen's Stelara (ingredient: uste
Pediatric leukemia is the most common cancer among children and adolescents.Most cases of pediatric leukemia manifest acutely, necessitating prompt intervention and treatment upon symptom onset. So what should you do when you notice symptoms in your child?We heard from Professor Hong Kyung-taek of S